UAB "ORION PHARMA" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,937,912 |
| 322,985 |
| 144,953 |
| 110,909 |
| 18,485 |
| 7.40 |
| 5.72 |
| 617,626 |
| 92,890 |
| 0 |
| 804,356 |
| 2023 |
|---|
| 1,557,627 |
| 180,281 |
| 130,690 |
| 111,435 |
| 12,898 |
| 7.41 |
| 7.15 |
| 328,625 |
| 239,126 |
| 0 |
| 585,928 |
| 2024 |
|---|
| 1,580,272 |
| 154,173 |
| 125,943 |
| 101,185 |
| 9,872 |
| 7.40 |
| 6.40 |
| 159,809 |
| 62,034 |
| 0 |
| 309,649 |
Register and
explore Okredo data| 2024 |
|---|
| 1,580,272 |
| 154,173 |
| 125,943 |
| 101,185 |
| 9,872 |
| 7.40 |
| 6.40 |
| 159,809 |
| 62,034 |
| 0 |
| 309,649 |
Register and
explore Okredo data2024
Turnover (€)
1,580,272 €
1 % *
Sales per employee (€)
154,173 €
-14 % *
Profit before tax (€)
125,943 €-4 % *
Net Profit (€)
101,185 €-9 % *
Profit per employee (€)
9,872 €-23 % *
Total profitability (%)
7.40 %-0.13 % *
Net profitability (%)
6.40 %-10.49 % *
Equity (€)
159,809 €-51 % *
Amounts Payable And Liabilities (€)
62,034 €
-74 % *
Non-current Assets (€)
0 €
- *
CurrentAssets (€)
309,649 €-47 % *